Organization & Developments: Enhance Diagnostics

Parents

*Developed an at-home breath test for ammonia, offering a convenient solution for both CKD and UCD patients
*For CKD patients, our device promises low-cost, non-invasive, and private testing, addressing the challenges associated with at-home monitoring.
*Platform demonstrates a strong correlation between breath ammonia and blood urea nitrogen (BUN) in CKD patients, as well as a direct correlation to blood ammonia levels in those with UCDs.
*Proper management of metabolic waste is essential for maintaining optimal health, particularly for individuals with chronic kidney disease (CKD) and urea cycle disorders (UCD).
*This innovation allows for quantitative, real-time patient monitoring at home, eliminating the need for frequent in-person visits and providing valuable insights without the necessity of a blood test.